Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
8.00
+0.32 (4.17%)
At close: Sep 26, 2025, 4:00 PM EDT
8.07
+0.07 (0.88%)
After-hours: Sep 26, 2025, 4:56 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $25.43 million as of September 26, 2025. Its market cap has decreased by -46.25% in one year.
Market Cap
25.43M
Enterprise Value
-7.47M
1-Year Change
-46.25%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $25.43M, a decrease of -97.34%. That is a compound annual growth rate of -47.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 25.43M | -27.40% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |